Impact of substance use on the onset and course of early psychosis
Identifieur interne :
001A03 ( PascalFrancis/Curation );
précédent :
001A02;
suivant :
001A04
Impact of substance use on the onset and course of early psychosis
Auteurs : Hélène Verdoux [
France] ;
Marie Toumier [
France] ;
Audrey Cougnard [
France]
Source :
-
Schizophrenia research [ 0920-9964 ] ; 2005.
RBID : Pascal:05-0468970
Descripteurs français
- Pascal (Inist)
- Toxicomanie,
Précoce,
Psychose,
Cannabis,
Facteur risque,
Schizophrénie,
Pronostic,
Association morbide,
Article synthèse,
Homme,
Abus de substance.
- Wicri :
English descriptors
- KwdEn :
- Cannabis,
Concomitant disease,
Drug addiction,
Early,
Human,
Prognosis,
Psychosis,
Review,
Risk factor,
Schizophrenia,
Substance abuse.
Abstract
The strong comorbidity between psychosis and substance use is already identifiable in early psychosis, raising the question of the direction of the association between substance use and psychosis onset. It has long been considered that this association was explained by the self-medication hypothesis. This hypothesis has been recently challenged by several prospective studies carried out in population-based samples, showing a dose-response relationship between cannabis exposure and risk of psychosis. This association was independent from potential confounding factors such as exposure to other drugs and preexistence of psychotic symptoms. As a large percentage of subjects from the general population is now exposed to this drug, even a small increase in the risk of adverse effects may have significant deleterious consequences for the health of the population. Hence, reducing exposure to cannabis may contribute to prevention of some incident cases of psychosis. Regarding prognosis, persistent substance misuse after the onset of psychosis has a deleterious impact on clinical outcome. Therapeutic programs for subjects with dual diagnosis should be implemented early in the course of psychosis to maximise their impact on the course of illness.
| pA |
| A01 | 01 | 1 | | @0 0920-9964 |
|---|
| A03 | | 1 | | @0 Schizophr. res. |
|---|
| A05 | | | | @2 79 |
|---|
| A06 | | | | @2 1 |
|---|
| A08 | 01 | 1 | ENG | @1 Impact of substance use on the onset and course of early psychosis |
|---|
| A09 | 01 | 1 | ENG | @1 Translating the evidence |
|---|
| A11 | 01 | 1 | | @1 VERDOUX (Hélène) |
|---|
| A11 | 02 | 1 | | @1 TOUMIER (Marie) |
|---|
| A11 | 03 | 1 | | @1 COUGNARD (Audrey) |
|---|
| A12 | 01 | 1 | | @1 ADDINGTON (Jean) @9 ed. |
|---|
| A14 | 01 | | | @1 EA 3676, IFR of Public Health, University Victor Segalen Bordeaux 2 @2 Bordeaux @3 FRA @Z 1 aut. @Z 2 aut. @Z 3 aut. |
|---|
| A15 | 01 | | | @1 University of Toronto, Psychiatry, CAMH, 250 College Street @2 Toronto, M5T 1R8 @3 CAN @Z 1 aut. |
|---|
| A18 | 01 | 1 | | @1 International Early Psychosis Association (IEPA) @2 Victoria @3 AUS @9 org-cong. |
|---|
| A20 | | | | @1 69-75 |
|---|
| A21 | | | | @1 2005 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 INIST @2 21734 @5 354000132747830070 |
|---|
| A44 | | | | @0 0000 @1 © 2005 INIST-CNRS. All rights reserved. |
|---|
| A45 | | | | @0 1 p.3/4 |
|---|
| A47 | 01 | 1 | | @0 05-0468970 |
|---|
| A60 | | | | @1 P @2 C |
|---|
| A61 | | | | @0 A |
|---|
| A64 | 01 | 1 | | @0 Schizophrenia research |
|---|
| A66 | 01 | | | @0 NLD |
|---|
| C01 | 01 | | ENG | @0 The strong comorbidity between psychosis and substance use is already identifiable in early psychosis, raising the question of the direction of the association between substance use and psychosis onset. It has long been considered that this association was explained by the self-medication hypothesis. This hypothesis has been recently challenged by several prospective studies carried out in population-based samples, showing a dose-response relationship between cannabis exposure and risk of psychosis. This association was independent from potential confounding factors such as exposure to other drugs and preexistence of psychotic symptoms. As a large percentage of subjects from the general population is now exposed to this drug, even a small increase in the risk of adverse effects may have significant deleterious consequences for the health of the population. Hence, reducing exposure to cannabis may contribute to prevention of some incident cases of psychosis. Regarding prognosis, persistent substance misuse after the onset of psychosis has a deleterious impact on clinical outcome. Therapeutic programs for subjects with dual diagnosis should be implemented early in the course of psychosis to maximise their impact on the course of illness. |
|---|
| C02 | 01 | X | | @0 002B18C05A |
|---|
| C02 | 02 | X | | @0 002B18C06A |
|---|
| C03 | 01 | X | FRE | @0 Toxicomanie @5 01 |
|---|
| C03 | 01 | X | ENG | @0 Drug addiction @5 01 |
|---|
| C03 | 01 | X | SPA | @0 Toxicomanía @5 01 |
|---|
| C03 | 02 | X | FRE | @0 Précoce @5 02 |
|---|
| C03 | 02 | X | ENG | @0 Early @5 02 |
|---|
| C03 | 02 | X | SPA | @0 Precoz @5 02 |
|---|
| C03 | 03 | X | FRE | @0 Psychose @5 03 |
|---|
| C03 | 03 | X | ENG | @0 Psychosis @5 03 |
|---|
| C03 | 03 | X | SPA | @0 Psicosis @5 03 |
|---|
| C03 | 04 | X | FRE | @0 Cannabis @2 NS @5 04 |
|---|
| C03 | 04 | X | ENG | @0 Cannabis @2 NS @5 04 |
|---|
| C03 | 04 | X | SPA | @0 Cannabis @2 NS @5 04 |
|---|
| C03 | 05 | X | FRE | @0 Facteur risque @5 05 |
|---|
| C03 | 05 | X | ENG | @0 Risk factor @5 05 |
|---|
| C03 | 05 | X | SPA | @0 Factor riesgo @5 05 |
|---|
| C03 | 06 | X | FRE | @0 Schizophrénie @5 06 |
|---|
| C03 | 06 | X | ENG | @0 Schizophrenia @5 06 |
|---|
| C03 | 06 | X | SPA | @0 Esquizofrenia @5 06 |
|---|
| C03 | 07 | X | FRE | @0 Pronostic @5 07 |
|---|
| C03 | 07 | X | ENG | @0 Prognosis @5 07 |
|---|
| C03 | 07 | X | SPA | @0 Pronóstico @5 07 |
|---|
| C03 | 08 | X | FRE | @0 Association morbide @5 08 |
|---|
| C03 | 08 | X | ENG | @0 Concomitant disease @5 08 |
|---|
| C03 | 08 | X | SPA | @0 Asociación morbosa @5 08 |
|---|
| C03 | 09 | X | FRE | @0 Article synthèse @5 09 |
|---|
| C03 | 09 | X | ENG | @0 Review @5 09 |
|---|
| C03 | 09 | X | SPA | @0 Artículo síntesis @5 09 |
|---|
| C03 | 10 | X | FRE | @0 Homme @5 18 |
|---|
| C03 | 10 | X | ENG | @0 Human @5 18 |
|---|
| C03 | 10 | X | SPA | @0 Hombre @5 18 |
|---|
| C03 | 11 | X | FRE | @0 Abus de substance @4 CD @5 96 |
|---|
| C03 | 11 | X | ENG | @0 Substance abuse @4 CD @5 96 |
|---|
| C03 | 11 | X | SPA | @0 Abuso de sustancias @4 CD @5 96 |
|---|
| C07 | 01 | X | FRE | @0 Cannabidaceae @2 NS |
|---|
| C07 | 01 | X | ENG | @0 Cannabidaceae @2 NS |
|---|
| C07 | 01 | X | SPA | @0 Cannabidaceae @2 NS |
|---|
| C07 | 02 | X | FRE | @0 Dicotyledones @2 NS |
|---|
| C07 | 02 | X | ENG | @0 Dicotyledones @2 NS |
|---|
| C07 | 02 | X | SPA | @0 Dicotyledones @2 NS |
|---|
| C07 | 03 | X | FRE | @0 Angiospermae @2 NS |
|---|
| C07 | 03 | X | ENG | @0 Angiospermae @2 NS |
|---|
| C07 | 03 | X | SPA | @0 Angiospermae @2 NS |
|---|
| C07 | 04 | X | FRE | @0 Spermatophyta @2 NS |
|---|
| C07 | 04 | X | ENG | @0 Spermatophyta @2 NS |
|---|
| C07 | 04 | X | SPA | @0 Spermatophyta @2 NS |
|---|
| N21 | | | | @1 332 |
|---|
|
|---|
| pR |
| A30 | 01 | 1 | ENG | @1 International conference on Early Psychosis @2 4 @3 Vancouver CAN @4 2004-09-28 |
|---|
|
|---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004700
Links to Exploration step
Pascal:05-0468970
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Impact of substance use on the onset and course of early psychosis</title>
<author><name sortKey="Verdoux, Helene" sort="Verdoux, Helene" uniqKey="Verdoux H" first="Hélène" last="Verdoux">Hélène Verdoux</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>EA 3676, IFR of Public Health, University Victor Segalen Bordeaux 2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Toumier, Marie" sort="Toumier, Marie" uniqKey="Toumier M" first="Marie" last="Toumier">Marie Toumier</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>EA 3676, IFR of Public Health, University Victor Segalen Bordeaux 2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Cougnard, Audrey" sort="Cougnard, Audrey" uniqKey="Cougnard A" first="Audrey" last="Cougnard">Audrey Cougnard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>EA 3676, IFR of Public Health, University Victor Segalen Bordeaux 2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0468970</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0468970 INIST</idno>
<idno type="RBID">Pascal:05-0468970</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">004700</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001A03</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Impact of substance use on the onset and course of early psychosis</title>
<author><name sortKey="Verdoux, Helene" sort="Verdoux, Helene" uniqKey="Verdoux H" first="Hélène" last="Verdoux">Hélène Verdoux</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>EA 3676, IFR of Public Health, University Victor Segalen Bordeaux 2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Toumier, Marie" sort="Toumier, Marie" uniqKey="Toumier M" first="Marie" last="Toumier">Marie Toumier</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>EA 3676, IFR of Public Health, University Victor Segalen Bordeaux 2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Cougnard, Audrey" sort="Cougnard, Audrey" uniqKey="Cougnard A" first="Audrey" last="Cougnard">Audrey Cougnard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>EA 3676, IFR of Public Health, University Victor Segalen Bordeaux 2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><series><title level="j" type="main">Schizophrenia research</title>
<title level="j" type="abbreviated">Schizophr. res.</title>
<idno type="ISSN">0920-9964</idno>
<imprint><date when="2005">2005</date>
</imprint><seriesStmt><title level="j" type="main">Schizophrenia research</title>
<title level="j" type="abbreviated">Schizophr. res.</title>
<idno type="ISSN">0920-9964</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cannabis</term>
<term>Concomitant disease</term>
<term>Drug addiction</term>
<term>Early</term>
<term>Human</term>
<term>Prognosis</term>
<term>Psychosis</term>
<term>Review</term>
<term>Risk factor</term>
<term>Schizophrenia</term>
<term>Substance abuse</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Toxicomanie</term>
<term>Précoce</term>
<term>Psychose</term>
<term>Cannabis</term>
<term>Facteur risque</term>
<term>Schizophrénie</term>
<term>Pronostic</term>
<term>Association morbide</term>
<term>Article synthèse</term>
<term>Homme</term>
<term>Abus de substance</term>
</keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Toxicomanie</term>
<term>Homme</term>
</keywords><front><div type="abstract" xml:lang="en">The strong comorbidity between psychosis and substance use is already identifiable in early psychosis, raising the question of the direction of the association between substance use and psychosis onset. It has long been considered that this association was explained by the self-medication hypothesis. This hypothesis has been recently challenged by several prospective studies carried out in population-based samples, showing a dose-response relationship between cannabis exposure and risk of psychosis. This association was independent from potential confounding factors such as exposure to other drugs and preexistence of psychotic symptoms. As a large percentage of subjects from the general population is now exposed to this drug, even a small increase in the risk of adverse effects may have significant deleterious consequences for the health of the population. Hence, reducing exposure to cannabis may contribute to prevention of some incident cases of psychosis. Regarding prognosis, persistent substance misuse after the onset of psychosis has a deleterious impact on clinical outcome. Therapeutic programs for subjects with dual diagnosis should be implemented early in the course of psychosis to maximise their impact on the course of illness.</div>
</front><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0920-9964</s0>
</fA01><fA03 i2="1"><s0>Schizophr. res.</s0>
</fA03><fA08 i1="01" i2="1" l="ENG"><s1>Impact of substance use on the onset and course of early psychosis</s1>
</fA08><fA09 i1="01" i2="1" l="ENG"><s1>Translating the evidence</s1>
</fA09><fA11 i1="01" i2="1"><s1>VERDOUX (Hélène)</s1>
</fA11><fA11 i1="02" i2="1"><s1>TOUMIER (Marie)</s1>
</fA11><fA11 i1="03" i2="1"><s1>COUGNARD (Audrey)</s1>
</fA11><fA12 i1="01" i2="1"><s1>ADDINGTON (Jean)</s1>
<s9>ed.</s9>
</fA12><fA14 i1="01"><s1>EA 3676, IFR of Public Health, University Victor Segalen Bordeaux 2</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14><fA15 i1="01"><s1>University of Toronto, Psychiatry, CAMH, 250 College Street</s1>
<s2>Toronto, M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</fA15><fA18 i1="01" i2="1"><s1>International Early Psychosis Association (IEPA)</s1>
<s2>Victoria</s2>
<s3>AUS</s3>
<s9>org-cong.</s9>
</fA18><fA20><s1>69-75</s1>
</fA20><fA21><s1>2005</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>INIST</s1>
<s2>21734</s2>
<s5>354000132747830070</s5>
</fA43><fA44><s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44><fA45><s0>1 p.3/4</s0>
</fA45><fA47 i1="01" i2="1"><s0>05-0468970</s0>
</fA47><fA60><s1>P</s1>
<s2>C</s2>
</fA60><fA64 i1="01" i2="1"><s0>Schizophrenia research</s0>
</fA64><fA66 i1="01"><s0>NLD</s0>
</fA66><fC01 i1="01" l="ENG"><s0>The strong comorbidity between psychosis and substance use is already identifiable in early psychosis, raising the question of the direction of the association between substance use and psychosis onset. It has long been considered that this association was explained by the self-medication hypothesis. This hypothesis has been recently challenged by several prospective studies carried out in population-based samples, showing a dose-response relationship between cannabis exposure and risk of psychosis. This association was independent from potential confounding factors such as exposure to other drugs and preexistence of psychotic symptoms. As a large percentage of subjects from the general population is now exposed to this drug, even a small increase in the risk of adverse effects may have significant deleterious consequences for the health of the population. Hence, reducing exposure to cannabis may contribute to prevention of some incident cases of psychosis. Regarding prognosis, persistent substance misuse after the onset of psychosis has a deleterious impact on clinical outcome. Therapeutic programs for subjects with dual diagnosis should be implemented early in the course of psychosis to maximise their impact on the course of illness.</s0>
</fC01><fC02 i1="01" i2="X"><s0>002B18C05A</s0>
</fC02><fC02 i1="02" i2="X"><s0>002B18C06A</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Toxicomanie</s0>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Drug addiction</s0>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Toxicomanía</s0>
<s5>01</s5>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Précoce</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Early</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Precoz</s0>
<s5>02</s5>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Psychose</s0>
<s5>03</s5>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Psychosis</s0>
<s5>03</s5>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Psicosis</s0>
<s5>03</s5>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Cannabis</s0>
<s2>NS</s2>
<s5>04</s5>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Cannabis</s0>
<s2>NS</s2>
<s5>04</s5>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Cannabis</s0>
<s2>NS</s2>
<s5>04</s5>
</fC03><fC03 i1="05" i2="X" l="FRE"><s0>Facteur risque</s0>
<s5>05</s5>
</fC03><fC03 i1="05" i2="X" l="ENG"><s0>Risk factor</s0>
<s5>05</s5>
</fC03><fC03 i1="05" i2="X" l="SPA"><s0>Factor riesgo</s0>
<s5>05</s5>
</fC03><fC03 i1="06" i2="X" l="FRE"><s0>Schizophrénie</s0>
<s5>06</s5>
</fC03><fC03 i1="06" i2="X" l="ENG"><s0>Schizophrenia</s0>
<s5>06</s5>
</fC03><fC03 i1="06" i2="X" l="SPA"><s0>Esquizofrenia</s0>
<s5>06</s5>
</fC03><fC03 i1="07" i2="X" l="FRE"><s0>Pronostic</s0>
<s5>07</s5>
</fC03><fC03 i1="07" i2="X" l="ENG"><s0>Prognosis</s0>
<s5>07</s5>
</fC03><fC03 i1="07" i2="X" l="SPA"><s0>Pronóstico</s0>
<s5>07</s5>
</fC03><fC03 i1="08" i2="X" l="FRE"><s0>Association morbide</s0>
<s5>08</s5>
</fC03><fC03 i1="08" i2="X" l="ENG"><s0>Concomitant disease</s0>
<s5>08</s5>
</fC03><fC03 i1="08" i2="X" l="SPA"><s0>Asociación morbosa</s0>
<s5>08</s5>
</fC03><fC03 i1="09" i2="X" l="FRE"><s0>Article synthèse</s0>
<s5>09</s5>
</fC03><fC03 i1="09" i2="X" l="ENG"><s0>Review</s0>
<s5>09</s5>
</fC03><fC03 i1="09" i2="X" l="SPA"><s0>Artículo síntesis</s0>
<s5>09</s5>
</fC03><fC03 i1="10" i2="X" l="FRE"><s0>Homme</s0>
<s5>18</s5>
</fC03><fC03 i1="10" i2="X" l="ENG"><s0>Human</s0>
<s5>18</s5>
</fC03><fC03 i1="10" i2="X" l="SPA"><s0>Hombre</s0>
<s5>18</s5>
</fC03><fC03 i1="11" i2="X" l="FRE"><s0>Abus de substance</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03><fC03 i1="11" i2="X" l="ENG"><s0>Substance abuse</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03><fC03 i1="11" i2="X" l="SPA"><s0>Abuso de sustancias</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03><fC07 i1="01" i2="X" l="FRE"><s0>Cannabidaceae</s0>
<s2>NS</s2>
</fC07><fC07 i1="01" i2="X" l="ENG"><s0>Cannabidaceae</s0>
<s2>NS</s2>
</fC07><fC07 i1="01" i2="X" l="SPA"><s0>Cannabidaceae</s0>
<s2>NS</s2>
</fC07><fC07 i1="02" i2="X" l="FRE"><s0>Dicotyledones</s0>
<s2>NS</s2>
</fC07><fC07 i1="02" i2="X" l="ENG"><s0>Dicotyledones</s0>
<s2>NS</s2>
</fC07><fC07 i1="02" i2="X" l="SPA"><s0>Dicotyledones</s0>
<s2>NS</s2>
</fC07><fC07 i1="03" i2="X" l="FRE"><s0>Angiospermae</s0>
<s2>NS</s2>
</fC07><fC07 i1="03" i2="X" l="ENG"><s0>Angiospermae</s0>
<s2>NS</s2>
</fC07><fC07 i1="03" i2="X" l="SPA"><s0>Angiospermae</s0>
<s2>NS</s2>
</fC07><fC07 i1="04" i2="X" l="FRE"><s0>Spermatophyta</s0>
<s2>NS</s2>
</fC07><fC07 i1="04" i2="X" l="ENG"><s0>Spermatophyta</s0>
<s2>NS</s2>
</fC07><fC07 i1="04" i2="X" l="SPA"><s0>Spermatophyta</s0>
<s2>NS</s2>
</fC07><fN21><s1>332</s1>
</fN21><pR><fA30 i1="01" i2="1" l="ENG"><s1>International conference on Early Psychosis</s1>
<s2>4</s2>
<s3>Vancouver CAN</s3>
<s4>2004-09-28</s4>
</fA30>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A03 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001A03 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:05-0468970
|texte= Impact of substance use on the onset and course of early psychosis
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
